What is Novavax's other income (expense)?

Novavax (NVAX) reported other income (expense) of $11.83M in Q1 2026.

How has Novavax's other income (expense) changed year-over-year?

Novavax's other income (expense) increased by 17.6% year-over-year, from $10.06M to $11.83M.

What is the long-term trend for Novavax's other income (expense)?

Over 4 years (2021 to 2025), Novavax's other income (expense) has grown at a 53.8% compound annual growth rate (CAGR), from -$7.27M to $40.63M.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Novavax NVAX Other Income (Expense)

Other Income (Expense) at other companies

ModernaMRNA

-$18M-350%

Roivant SciencesROIV

$12.57M+542%

Vaxcyte, Inc.PCVX

$25.23M-37.0%

Viridian Therapeutics, Inc.VRDN

$11.27M+62.0%

ALN

Alnylam PharmaceuticalsALNY

-$46.98M-130%

Gilead SciencesGILD

$235M+172%

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's other income (expense)?: Novavax (NVAX) reported other income (expense) of $11.83M in Q1 2026.
How has Novavax's other income (expense) changed year-over-year?: Novavax's other income (expense) increased by 17.6% year-over-year, from $10.06M to $11.83M.
What is the long-term trend for Novavax's other income (expense)?: Over 4 years (2021 to 2025), Novavax's other income (expense) has grown at a 53.8% compound annual growth rate (CAGR), from -$7.27M to $40.63M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.